145 related articles for article (PubMed ID: 19960436)
1. Phosphatase of regenerating liver-3 as a convergent therapeutic target for lymph node metastasis in esophageal squamous cell carcinoma.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Watanabe M
Int J Cancer; 2010 Aug; 127(3):543-54. PubMed ID: 19960436
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
[TBL] [Abstract][Full Text] [Related]
3. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
[TBL] [Abstract][Full Text] [Related]
4. Expression of phosphatase of regenerating liver 1 and 3 mRNA in esophageal squamous cell carcinoma.
Liu YQ; Li HX; Lou X; Lei JY
Arch Pathol Lab Med; 2008 Aug; 132(8):1307-12. PubMed ID: 18684031
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
Wang Z; He YL; Cai SR; Zhan WH; Li ZR; Zhu BH; Chen CQ; Ma JP; Chen ZX; Li W; Zhang LJ
Int J Cancer; 2008 Sep; 123(6):1439-47. PubMed ID: 18561324
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
Lou X; Liu Y; Lei JY; Li H
Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
[TBL] [Abstract][Full Text] [Related]
7. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
8. A selective phosphatase of regenerating liver phosphatase inhibitor suppresses tumor cell anchorage-independent growth by a novel mechanism involving p130Cas cleavage.
Daouti S; Li WH; Qian H; Huang KS; Holmgren J; Levin W; Reik L; McGady DL; Gillespie P; Perrotta A; Bian H; Reidhaar-Olson JF; Bliss SA; Olivier AR; Sergi JA; Fry D; Danho W; Ritland S; Fotouhi N; Heimbrook D; Niu H
Cancer Res; 2008 Feb; 68(4):1162-9. PubMed ID: 18281492
[TBL] [Abstract][Full Text] [Related]
9. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
[TBL] [Abstract][Full Text] [Related]
11. Rhodanine-based PRL-3 inhibitors blocked the migration and invasion of metastatic cancer cells.
Min G; Lee SK; Kim HN; Han YM; Lee RH; Jeong DG; Han DC; Kwon BM
Bioorg Med Chem Lett; 2013 Jul; 23(13):3769-74. PubMed ID: 23726031
[TBL] [Abstract][Full Text] [Related]
12. Liver metastasis of colorectal cancer by protein-tyrosine phosphatase type 4A, 3 (PRL-3) is mediated through lymph node metastasis and elevated serum tumor markers such as CEA and CA19-9.
Hatate K; Yamashita K; Hirai K; Kumamoto H; Sato T; Ozawa H; Nakamura T; Onozato W; Kokuba Y; Ihara A; Watanabe M
Oncol Rep; 2008 Oct; 20(4):737-43. PubMed ID: 18813812
[TBL] [Abstract][Full Text] [Related]
13. PCBP1 suppresses the translation of metastasis-associated PRL-3 phosphatase.
Wang H; Vardy LA; Tan CP; Loo JM; Guo K; Li J; Lim SG; Zhou J; Chng WJ; Ng SB; Li HX; Zeng Q
Cancer Cell; 2010 Jul; 18(1):52-62. PubMed ID: 20609352
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
[TBL] [Abstract][Full Text] [Related]
15. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
16. The dual inhibition against the activity and expression of tyrosine phosphatase PRL-3 from a rhodanine derivative.
Lin L; Lu L; Yuan C; Wang A; Zhu M; Fu X; Xing S
Bioorg Med Chem Lett; 2021 Jun; 41():127981. PubMed ID: 33766767
[TBL] [Abstract][Full Text] [Related]
17. PRL-3 phosphatase is implicated in ovarian cancer growth.
Polato F; Codegoni A; Fruscio R; Perego P; Mangioni C; Saha S; Bardelli A; Broggini M
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6835-9. PubMed ID: 16203771
[TBL] [Abstract][Full Text] [Related]
18. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma.
Zhou J; Wang S; Lu J; Li J; Ding Y
Int J Cancer; 2009 Apr; 124(8):1879-86. PubMed ID: 19101992
[TBL] [Abstract][Full Text] [Related]
20. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma.
Yang YL; Chu JY; Luo ML; Wu YP; Zhang Y; Feng YB; Shi ZZ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
Genes Chromosomes Cancer; 2008 Feb; 47(2):127-36. PubMed ID: 17990328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
